Use of APO-DASATINIB is contraindicated in patients with hypersensitivity to dasatinib or to any other component of APO-DASATINIB.
Breastfeeding is contraindicated in women taking dasatinib.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.